nivolumab,ipilimumab
bms
[]
great study, approaching the clinically important question of io duration this emphasises the importance of academic studies, academia can and should continue to ask these types of questions 
Thoracic Oncologist focused on immunotherapy for lung cancer & immune toxicity at Beaumont RCSI Cancer Centre Dublin; Adjunct Professor Johns Hopkins University